4 Recruiting Nsclc Stage Iv Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Recruiting Nsclc Stage Iv Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Plasma-Adapted First-Line Pembro In NSCLC
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
📍 The University of Kansas Cancer Center (KUCC) — Fairway, Kansas
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
📍 Highlands Oncology Group — Springdale, Arkansas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
📍 Johns Hopkins University — Baltimore, Maryland
View Study & Checklist ➔